Data / Form D filings / PSYENCE BIOMEDICAL LTD.
PSYENCE BIOMEDICAL LTD.: Form D filing
PSYENCE BIOMEDICAL LTD., a biotechnology company in Toronto, Ontario, Canada, filed a Form D with the SEC in 2025. The latest, on January 7, 2025, reports $2 million sold of a $2 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 121 RICHMOND STREET WEST PENTHOUSE, SUITE 1300, Toronto, Ontario, Canada, M5H 2
- Phone
- + 1 (416) 346-7764
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1985062
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | New notice | $2,000,000 | $2,000,000 | 2 | Dec 27, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bull Christopher | Director | |
| Jody Aufrichtig | Executive Officer, Director | |
| Neil Maresky | Executive Officer, Director | |
| Dr. Seth Feuerstein | Director | |
| Marc Balkin | Director | |
| Warwick Corden-Lloyd | Executive Officer |
Every Form D from the week of Jan 6, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PSYENCE BIOMEDICAL LTD. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.